- Home
- PULM vs FPAY Comparison
PULM vs FPAY Comparison
Compare PULM & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- FPAY
- Stock Information
- Founded
- PULM 2003
- FPAY 2003
- Country
- PULM United States
- FPAY United States
- Employees
- PULM N/A
- FPAY N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- FPAY Diversified Commercial Services
- Sector
- PULM Health Care
- FPAY Consumer Discretionary
- Exchange
- PULM Nasdaq
- FPAY Nasdaq
- Market Cap
- PULM 33.2M
- FPAY 27.2M
- IPO Year
- PULM N/A
- FPAY N/A
- Fundamental
- Price
- PULM $6.38
- FPAY $1.08
- Analyst Decision
- PULM
- FPAY Strong Buy
- Analyst Count
- PULM 0
- FPAY 2
- Target Price
- PULM N/A
- FPAY $3.25
- AVG Volume (30 Days)
- PULM 60.0K
- FPAY 87.0K
- Earning Date
- PULM 08-12-2025
- FPAY 08-05-2025
- Dividend Yield
- PULM N/A
- FPAY N/A
- EPS Growth
- PULM N/A
- FPAY N/A
- EPS
- PULM N/A
- FPAY N/A
- Revenue
- PULM $1,921,000.00
- FPAY $139,800,732.00
- Revenue This Year
- PULM N/A
- FPAY $16.58
- Revenue Next Year
- PULM $134.88
- FPAY N/A
- P/E Ratio
- PULM N/A
- FPAY N/A
- Revenue Growth
- PULM N/A
- FPAY 19.51
- 52 Week Low
- PULM $1.78
- FPAY $0.84
- 52 Week High
- PULM $10.40
- FPAY $2.37
- Technical
- Relative Strength Index (RSI)
- PULM 39.53
- FPAY 43.10
- Support Level
- PULM $6.26
- FPAY $0.84
- Resistance Level
- PULM $6.96
- FPAY $1.17
- Average True Range (ATR)
- PULM 0.85
- FPAY 0.09
- MACD
- PULM -0.11
- FPAY -0.01
- Stochastic Oscillator
- PULM 39.71
- FPAY 58.70
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.